Shift Up’s popular mobile game NIKKE is preparing for its market debut in China under a modified title Goddess of Victory: New Hope, following a 10-month collaboration between publisher Migu and Chinese regulatory authorities. The pre-registration campaign launched on January 9, 2025, has sparked discussions within the global NIKKE community regarding potential implications for the game’s future.
The Chinese version features notably altered character designs, with the initial reveal showcasing modified versions of key characters Rapi, Anis, and Neon. Changes include reduced exposure, additional fabric coverage, and more conservative outfits compared to the global version. This follows established patterns of content modification seen in other games like Fate/Grand Order and Azur Lane for the Chinese market.
The approval comes as part of a broader wave of gaming licenses, which includes 113 domestic titles and 15 foreign games. This relatively small number of foreign approvals highlights the significance of New Hope’s entry into the Chinese market, as international titles face a more selective approval process.
Community concerns extend beyond aesthetic changes, with players expressing worry about potential IP location restrictions, story modifications, and cross-server interactions. The global NIKKE community has noted particular concern about whether these modifications might influence future character designs across all servers.
Migu, the Chinese publisher, has positioned this successful adaptation as a model for other international game companies seeking to enter the Chinese market. While early 2025 speculation suggested the Chinese registration might have been solely for IP protection, the full launch announcement has confirmed actual release plans.
The approval of NIKKE reflects of the ongoing effort of China to revitalize its gaming industry following restrictive measures implemented in 2021. While maintaining a consistent approval rate of over 100 domestic games monthly throughout the year, foreign titles receive approvals less frequently, typically every two months.